Literature DB >> 9862704

A region of conformational variability outside the peptide-binding site of a class I MHC molecule.

S T Kuhns1, L R Pease.   

Abstract

Peptide binding is known to influence the conformation of the surface of class I molecules as detected with mAbs and TCR. A new conformationally sensitive epitope on the mouse class I molecule Kb is defined by mAb AF6-88.5. The recognized structure is affected by amino acid substitutions in any of the three external domains of the class I heavy chain and, in addition, is influenced by the substitution of human for mouse beta2-microglobulin. Interestingly, the epitope for this Ab is not affected by mutations within the peptide-binding cleft or by the nature of the peptide bound. These findings indicate that the effect of a change in one domain of class I can radiate to other parts of the molecule. Furthermore, the existence of conformationally sensitive structures outside of the peptide-binding site suggests the possibility that class I molecules may change their structure in response to binding by receptors and ligands such as the TCR and the coligand CD8. Such structural changes may represent signals that can influence cellular activation events.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862704

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Receptor/ligand avidity determines the capacity of Ly49 inhibitory receptors to interfere with T-cell receptor-mediated activation.

Authors:  Anick Chalifour; Joanne Roger; Suzanne Lemieux; Pascale Duplay
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

2.  RNA polymerase II inhibitors dissociate antigenic peptide generation from normal viral protein synthesis: a role for nuclear translation in defective ribosomal product synthesis?

Authors:  Brian P Dolan; Jonathan J Knowlton; Alexandre David; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2010-11-03       Impact factor: 5.422

Review 3.  Regulation of the Cell Biology of Antigen Cross-Presentation.

Authors:  J Magarian Blander
Journal:  Annu Rev Immunol       Date:  2018-02-28       Impact factor: 28.527

Review 4.  Spotlight on TAP and its vital role in antigen presentation and cross-presentation.

Authors:  Ian Mantel; Barzan A Sadiq; J Magarian Blander
Journal:  Mol Immunol       Date:  2021-12-29       Impact factor: 4.174

5.  Antitumor activity of epigenetic immunomodulation combined with CTLA-4 blockade in syngeneic mouse models.

Authors:  A Covre; S Coral; H Nicolay; G Parisi; C Fazio; F Colizzi; E Fratta; A M Di Giacomo; L Sigalotti; P G Natali; M Maio
Journal:  Oncoimmunology       Date:  2015-04-02       Impact factor: 8.110

Review 6.  The comings and goings of MHC class I molecules herald a new dawn in cross-presentation.

Authors:  J Magarian Blander
Journal:  Immunol Rev       Date:  2016-07       Impact factor: 12.988

7.  Nonequivalence of classical MHC class I loci in ability to direct effective antiviral immunity.

Authors:  Kevin D Pavelko; Yanice Mendez-Fernandez; Michael P Bell; Michael J Hansen; Aaron J Johnson; Chella S David; Moses Rodriguez; Larry R Pease
Journal:  PLoS Pathog       Date:  2012-02-23       Impact factor: 6.823

8.  A biodegradable killer microparticle to selectively deplete antigen-specific T cells in vitro and in vivo.

Authors:  Wei Wang; Kun Fang; Miao-Chen Li; Di Chang; Khawar Ali Shahzad; Tao Xu; Lei Zhang; Ning Gu; Chuan-Lai Shen
Journal:  Oncotarget       Date:  2016-03-15

9.  Frequency and reactivity of antigen-specific T cells were concurrently measured through the combination of artificial antigen-presenting cell, MACS and ELISPOT.

Authors:  Chuanlai Shen; Tao Xu; You Wu; Xiaoe Li; Lingzhi Xia; Wei Wang; Khawar Ali Shahzad; Lei Zhang; Xin Wan; Jie Qiu
Journal:  Sci Rep       Date:  2017-11-27       Impact factor: 4.379

10.  The role of MHC class I recycling and Arf6 in cross-presentation by murine dendritic cells.

Authors:  Sebastian Montealegre; Anastasia Abramova; Valerie Manceau; Anne-Floor de Kanter; Peter van Endert
Journal:  Life Sci Alliance       Date:  2019-11-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.